Atossa Therapeutics Responds to PTAB Ruling on U.S. Patent No. 11,572,334 and Announces the Issuance of U.S. Patent No. 12,201,591
Atossa is also announcing the issuance of a new patent on January 21, 2025, U.S. Patent No. 12,201,591, entitled, “Sustained Release Compositions of Endoxifen.” The 31 claims of this new patent are ...
ClearSign Technologies Corporation Awarded Federal Grant to Advance Hydrogen Burner Solutions for Industrial Decarbonization
ClearSign Technologies Corporation (Nasdaq: CLIR) ("ClearSign" or the "Company"), an emerging leader in industrial combustion and sensing technologies that support decarbonization, improve operational ...
Allegro MicroSystems Reports Third Quarter 2025 Results
Allegro MicroSystems, Inc. (“Allegro” or the “Company”) (Nasdaq: ALGM), a global leader in power and sensing semiconductor solutions for motion control and energy efficient systems, today announced ...
Markets regulatory Sebi cancels registration of 4 stock brokers; Here's why
Following the proper procedures outlined in the Intermediaries Regulations, 2008, SEBI has cancelled the registration ...